View Older Stories View More Recent Stories
-
Kala Pharmaceuticals Announces Closing of $68 Million Series C Financing
-
Eiger BioPharmaceuticals Closes Merger With Celladon
-
Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31
-
Form SC 13G/A VICAL INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Xencor Inc Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ACADIA PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A SCYNEXIS INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Arbutus Biopharma Corp Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A AGILE THERAPEUTICS INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A DYNAVAX TECHNOLOGIES Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A TREVENA INC Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Aclaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Cidara Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A BIOCRYST PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A WaferGen Bio-systems, Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Aurinia Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Blueprint Medicines Corp Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A COLLEGIUM PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ARDELYX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A AmpliPhi Biosciences Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A PROTEON THERAPEUTICS Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ZOGENIX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A TENAX THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Zynerba Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Regulus Therapeutics Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G Axovant Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A AQUINOX PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ARCA biopharma, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G DERMA SCIENCES, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form 4 Aclaris Therapeutics, For: Jan 15 Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form 4 Aclaris Therapeutics, For: Jan 11 Filed by: RA CAPITAL MANAGEMENT, LLC
-
PlacementTracker Publishes 2015 PIPE Market League Tables
-
Form SC 13D Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Notable Mergers and Acquisitions 11/19: (PFE)/(AGN) (VHI) (TDG)/(BZC) (CC)/(DOW)
-
Celladon (CLDN), Eiger BioPharma Enter Merger Agreement
-
Eiger BioPharmaceuticals and Celladon Corporation Sign Merger Agreement
-
Eiger BioPharmaceuticals and Celladon Corporation Sign Merger Agreement
-
Form 4 Wave Life Sciences Ltd. For: Aug 14 Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form SC 13G/A ALCOBRA LTD. Filed by: RA CAPITAL MANAGEMENT, LLC
-
Aclaris Therapeutics Reports Third Quarter 2015 Financial Results
-
Aclaris Therapeutics Reports Third Quarter 2015 Financial Results
-
Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30
-
Qvella Raises US$20M in Series A Financing From Leading US and Canadian Venture Funds
-
Form SC 13G Strongbridge Biopharma Filed by: RA CAPITAL MANAGEMENT, LLC
-
Form 4 Aclaris Therapeutics, For: Oct 19 Filed by: RA CAPITAL MANAGEMENT, LLC
-
Arvinas Secures $41.6M Series B Financing - Appoints New Board Members
-
Form 4 Aclaris Therapeutics, For: Oct 14 Filed by: RA CAPITAL MANAGEMENT, LLC

